New York, NY · Founded 2020 · Privately Held (backing)
Developer of a patient micro avatar platform designed to get the cancer therapy to the right patient. OncoPrecision is based in New York, NY and was founded in 2020. Its last reported valuation was $18 million in Oct 2025. It has raised $8.7 million.
Last reported valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$8.7M
Last round
—
Cap table — not yet on record
OncoPrecision's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of OncoPrecision with a free account
·Watch OncoPrecision: the Monday email on marks, rounds and moves
